Vividion

Frontier Medicines

This biopharmaceutical company develops small-molecule precision medicines targeting undruggable proteins for patients with cancer and immunological diseases.

Eikon Therapeutics

This biopharmaceutical company develops small molecule medicines for patients with cancer and other serious diseases using a live-cell imaging drug discovery platform.

Auron Therapeutics

This company develops small-molecule drugs using an AI-powered platform to treat patients with cancer and inflammatory diseases.

Enodia

This company develops small-molecule therapies that degrade disease-causing proteins at the point of synthesis for patients with cancer and inflammatory diseases.

Ambagon Therapeutics

The company develops small-molecule stabilisers to modulate protein interactions for the treatment of cancer and other serious diseases.

Allorion

This biotechnology company develops small-molecule drugs for patients with cancer and autoimmune diseases using its proprietary drug discovery platforms.

Reax

This company develops chemical proteomic platform technologies to discover small molecule therapeutics for patients with cancer and immunological diseases.

Acrivon Therapeutics

This biopharmaceutical company develops precision oncology medicines and proteomics-based companion diagnostics for cancer patients.